Actively Recruiting
TBE Zone 2 PMS in Japan
Led by W.L.Gore & Associates · Updated on 2026-02-05
200
Participants Needed
1
Research Sites
424 weeks
Total Duration
On this page
Sponsors
W
W.L.Gore & Associates
Lead Sponsor
C
CMIC Co, Ltd. Japan
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this surveillance is to confirm the TBE device's safety and efficacy in patients treated with proximal landing in Zone 2 in the post-marketing period.
CONDITIONS
Official Title
TBE Zone 2 PMS in Japan
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Suitable for use of the Gore TAG Thoracic Branch Endoprosthesis according to Japan package insert
- Diagnosis of thoracic aortic aneurysm
- Diagnosis of traumatic transection involving the thoracic aorta
- Diagnosis of complicated Stanford type B aortic dissection not responding to medical therapy
- Anatomical suitability to preserve blood flow to the left subclavian artery during treatment
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The University of Osaka Hospital
Osaka, Suita, Japan, 565-0871
Actively Recruiting
Research Team
H
Hideyuki Saigusa
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here